The thiazolidinedione insulin sensitiser, BRL 49653, increases the expression of PPAR-gamma and aP2 in adipose tissue of high-fat-fed rats

Biochem Biophys Res Commun. 1996 Dec 24;229(3):752-7. doi: 10.1006/bbrc.1996.1876.

Abstract

The effects of the thiazolidinedione insulin sensitiser BRL 49653 on plasma leptin concentrations and on epididymal fat OB, PPAR-gamma and aP2 mRNA expression were examined in high-fat-fed and high-carbohydrate-fed adult Wistar rats. Diets were given for 4 weeks, with BRL 49653 (10 micromol/kg/day) administered by oral gavage for the last 4 days. Treatment with BRL 49653 reduced plasma leptin concentrations in high-fat-fed rats from 2.34 +/- 0.19 (n=9) to 1.42 +/- 0.09 (n=9) ng/ml (p<0.001). Plasma leptin was unaffected by BRL 49653 in the high-carbohydrate-fed rats. There was no difference in OB mRNA expression between high-fat-fed and high-carbohydrate-fed rats, with or without treatment. PPAR-gamma and aP2 mRNA expression were significantly increased in the high-fat-fed rats treated with BRL 49653 (p < 0.01 and p < 0.001 respectively), but not in carbohydrate-fed rats.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adipose Tissue / metabolism*
  • Animals
  • Carrier Proteins / biosynthesis*
  • Dietary Fats / administration & dosage*
  • Fatty Acid-Binding Protein 7
  • Fatty Acid-Binding Proteins
  • Hypoglycemic Agents / pharmacology*
  • Male
  • Myelin P2 Protein / biosynthesis*
  • Neoplasm Proteins*
  • Nerve Tissue Proteins*
  • RNA, Messenger / analysis
  • Rats
  • Rats, Wistar
  • Receptors, Cytoplasmic and Nuclear / biosynthesis*
  • Rosiglitazone
  • Thiazoles / pharmacology*
  • Thiazolidinediones*
  • Transcription Factors / biosynthesis*

Substances

  • Carrier Proteins
  • Dietary Fats
  • Fabp7 protein, rat
  • Fatty Acid-Binding Protein 7
  • Fatty Acid-Binding Proteins
  • Hypoglycemic Agents
  • Myelin P2 Protein
  • Neoplasm Proteins
  • Nerve Tissue Proteins
  • RNA, Messenger
  • Receptors, Cytoplasmic and Nuclear
  • Thiazoles
  • Thiazolidinediones
  • Transcription Factors
  • Rosiglitazone